Clinical Evidence

Proven Efficacy Through Scientific Validation

Multi-Parameter Clinical Evaluation

Ostizeel™ has been clinically evaluated through multiple research studies to establish its effectiveness in addressing the multifactorial nature of osteoarthritis (OA). The formulation is designed to improve joint function, relieve pain, reduce inflammation, and protect cartilage integrity by targeting both nociceptive and neuropathic pathways.

Osteoarthritis is not a single-symptom disorder. It affects structural, neurological, and functional aspects of joint health. Ostizeel™ was assessed using standard global clinical evaluation tools, ensuring comprehensive measurement of its impact across multiple domains: WOMAC Score. VAS Score. LFI Score.

Pain Reduction

Significant reduction in joint pain was observed starting from Day 3, sustained over the treatment duration.

Enhanced Mobility

Increased joint range of motion, especially in knee flexion at 60°/s and 90°/s, reflecting improved mechanical function.

Cartilage Protection

Marked inhibition of cartilage-degrading enzymes (MMPs), leading to better joint structure preservation.